phenoxybenzamine has been researched along with Atrophy in 2 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| WADE, G | 1 |
| Okamura, H | 1 |
| Okazaki, T | 1 |
| Nakajima, A | 1 |
2 other studies available for phenoxybenzamine and Atrophy
| Article | Year |
|---|---|
RAYNAUD'S PHENOMENON.
Topics: Arteritis; Atrophy; Collagen Diseases; Diagnosis; Diagnosis, Differential; Drug Therapy; Humans; Occ | 1965 |
Effects of neurotransmitters and prostaglandins on human ovarian contractility.
Topics: Acetylcholine; Adult; Age Factors; Atrophy; Atropine; Female; Humans; Isoxsuprine; Middle Aged; Nore | 1974 |